Literature DB >> 3090687

Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins.

D Bar-Sagi, J R Feramisco.   

Abstract

Expression of the ras oncogene is thought to be one of the contributing events in the initiation of certain types of human cancer. To determine the cellular activities that are directly triggered by ras proteins, the early consequences of microinjection of the human H-ras proteins into quiescent rat embryo fibroblasts were investigated. Within 30 minutes to 1 hour after injection, cells show a marked increase in surface ruffles and fluid-phase pinocytosis. The rapid enhancement of membrane ruffling and pinocytosis is induced by both the proto-oncogenic and the oncogenic forms of the H-ras protein. The effects produced by the oncogenic protein persist for more than 15 hours after injection, whereas the effects of the proto-oncogenic protein are short-lived, being restricted to a 3-hour interval after injection. The stimulatory effect of the ras oncogene protein on ruffling and pinocytosis is dependent on the amount of injected protein and is accompanied by an apparent stimulation of phospholipase A2 activity. These rapid changes in cell membrane activities induced by ras proteins may represent primary events in the mechanism of action of ras proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090687     DOI: 10.1126/science.3090687

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  235 in total

1.  Rab5 induces Rac-independent lamellipodia formation and cell migration.

Authors:  M Spaargaren; J L Bos
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

2.  Phosphatidylinositol 3-kinase, Cdc42, and Rac1 act downstream of Ras in integrin-dependent neurite outgrowth in N1E-115 neuroblastoma cells.

Authors:  S Sarner; R Kozma; S Ahmed; L Lim
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Induced expression of Rnd3 is associated with transformation of polarized epithelial cells by the Raf-MEK-extracellular signal-regulated kinase pathway.

Authors:  S H Hansen; M M Zegers; M Woodrow; P Rodriguez-Viciana; P Chardin; K E Mostov; M McMahon
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  Regulation of Cdc42-mediated morphological effects: a novel function for p53.

Authors:  Gilles Gadéa; Laure Lapasset; Cécile Gauthier-Rouvière; Pierre Roux
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

5.  Regulation of macropinocytosis by p21-activated kinase-1.

Authors:  S Dharmawardhane; A Schürmann; M A Sells; J Chernoff; S L Schmid; G M Bokoch
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

6.  Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C.

Authors:  M Amyere; B Payrastre; U Krause; P Van Der Smissen; A Veithen; P J Courtoy
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

7.  H-Ras signaling and K-Ras signaling are differentially dependent on endocytosis.

Authors:  Sandrine Roy; Bruce Wyse; John F Hancock
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.

Authors:  B M Burgering; A J Snijders; J A Maassen; A J van der Eb; J L Bos
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

9.  Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation.

Authors:  M L Gishizky; D Cortez; A M Pendergast
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin.

Authors:  Darin Salloum; Suman Mukhopadhyay; Kaity Tung; Aleksandra Polonetskaya; David A Foster
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.